An elderly case of severe MRSA pneumonia successfully treated with linezolid

Kitakanto Medical Journal

Volumn 58, Issue 1, 2008, Pages 81-86

  Kato, Mari ^a   Hisada, Takeshi ^a,b   Ishizuka, Tamotsu ^b   Aoki, Haruka ^b   Yanagitani, Noriko ^b   Kaira, Kyoichi ^b   Utsugi, Mitsuyoshi ^b   Shimizu, Yasuo ^b   Sunaga, Noriaki ^b   Dobashi, Kunio ^c   Mori, Masatomo ^b   Kuwabara, Hidemasa ^a  

^a Numata Hospital

^b GUNMA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c GUNMA UNIVERSITY   (Japan)

Author keywords

Drug resistance; Elderly patients; Linezolid; MRSA pneumonia; Vancomycin

Indexed keywords

EID: 40949163118     PISSN: 13432826     EISSN: None     Source Type: Journal    
DOI: 10.2974/kmj.58.81     Document Type: Article

References (9)

1. Kaatz GW, Seo SM. In Vitro activities of oxazolidinone compounds U-100592 and U-100766 against Staphylococcus aureus and Staphylococcus epidermidis. Antimicrob Agents Chemother 1996; 40: 799-801.
2. Fines M, Leclercr R. Activity of linezolid against Gram-positive cocci possessing genes conferring resistance to protein synthesis inhibitors. J Antimicrob Chemother 2000; 45: 797-802.
3. Japanese source
4. Yanagihara K, Kaneko Y, Kohno S, et al. Efficacy of linezolid against methicillin-resistant or vancomycin-insensitive Staphylococcus aureus in a model of hematogenous pulmonary infection. Antimicrob Agents Chemother 2002; 46: 3288-3291.
5. Wunderink RG, Rello J, Kollef MH, et al. Chest 2003; 124: 1789-1797.
6. Rubinstein E, Isturiz R, Standiford HC, et al. World-wide assessment of linezolid's clinical safety and tolerability: comparator-controlled phase III studies. Antimicrob Agents Chemother 2003; 47: 1824-1831.
7. Conte JE, Golden JA, Kipps J, et al. Intrapulmonary pharmacokinetics of linezolid. Antimicrob Agents Chemother 2002; 46: 1475-1480.
8. Tsiodras S, Gold HS, Sakoulas G, et al. Linezolid resistance in a clinical isolate of Staphylococcus aureus. Lancet 2001; 358: 207-208.
9. Bassetti M, Farrel PA, Callan DA, et al. Emergence of linezolid-resistant Enterococcus Faecium during treatment of enterococcal infections. Int J Antimicrob Agents 2003; 21: 593-594.